Signup Crypto ETF Stocks News

Looking Into Sun Communities's Recent Short Interest - Sun Communities ( NYSE:SUI )

Sun Communities's SUI short percent of float has risen 4.98% since its last report. The company recently reported that it has 2.60 million shares sold short, which is 2.74% of all regular shares that are available for trading.

Source: www.benzinga.com
February 20, 2025 | 17:45:30
Category: News

ON Semiconductor's Options Frenzy: What You Need to Know - ON Semiconductor ( NASDAQ:ON )

Investors with a lot of money to spend have taken a bullish stance on ON Semiconductor ON. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

Source: www.benzinga.com
February 20, 2025 | 18:00:31
Category: News

Pediatrix Q4 Beats Estimates As Operational Improvements Drive Performance - Pediatrix Medical Group ( NYSE:MD )

Q4 revenue hit $502.36 million, exceeding the $486.21 million consensus, with an 8.7% same-unit revenue increase. Adjusted EPS rose to 51 cents, beating the 37 cents estimate, as payor mix and cost cuts boosted margins.

Source: www.benzinga.com
February 20, 2025 | 18:06:15
Category: News

Amid Mounting Pressure In China, AstraZeneca Buys FibroGen's Chinese Unit For $160 Million - AstraZeneca ( NASDAQ:AZN ) , FibroGen ( NASDAQ:FGEN )

FibroGen sells its China unit to AstraZeneca for about $160M, strengthening its cash position and extending its financial runway into 2027. AstraZeneca gains full rights to roxadustat in China, while FibroGen retains US rights and plans an FDA meeting for next development steps.

Source: www.benzinga.com
February 20, 2025 | 18:08:04
Category: News

Why Is Penny Stock Aptose Biosciences Trading Higher On Thursday? - Aptose Biosciences ( NASDAQ:APTO )

The TUS+VEN+AZA triplet showed no dose-limiting toxicities in the first four patients, allowing escalation from 40 mg to 80 mg tuspetinib. Two FLT3-WT patients achieved complete remissions after Cycle 1, while another showed significant blast reduction and remains in therapy.

Source: www.benzinga.com
February 20, 2025 | 18:11:15
Category: News

EQT Dips, But JPMorgan Stays Bullish With Higher Price Forecast - EQT ( NYSE:EQT )

JP Morgan raises EQT price target to $58, citing strong 2025 outlook and potential conservative guidance. 2025 production forecast at 2,257 Bcfe with $2.2B FCF at $3.53/Mcf, aligning with company guidance. Get two weeks of free access to pro-level trading tools, including news alerts, scanners, ...

Source: www.benzinga.com
February 20, 2025 | 18:12:20
Category: News

A Closer Look at Teck Resources's Options Market Dynamics - Teck Resources ( NYSE:TECK )

Investors with a lot of money to spend have taken a bullish stance on Teck Resources TECK. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

Source: www.benzinga.com
February 20, 2025 | 18:15:31
Category: News

Looking At American Airlines Gr's Recent Unusual Options Activity - American Airlines Gr ( NASDAQ:AAL )

Financial giants have made a conspicuous bullish move on American Airlines Gr. Our analysis of options history for American Airlines Gr AAL revealed 12 unusual trades. Delving into the details, we found 75% of traders were bullish, while 16% showed bearish tendencies.

Source: www.benzinga.com
February 20, 2025 | 18:15:42
Category: News

Class Action Filed Against ESSA Pharma Inc. ( EPIX ) Seeking Recovery for Investors - Contact The Gross Law Firm - ESSA Pharma ( NASDAQ:EPIX )

NEW YORK, Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of ESSA Pharma Inc. EPIX. Shareholders who purchased shares of EPIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Source: www.benzinga.com
February 20, 2025 | 18:22:00
Category: News

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 21, 2025 in AstraZeneca PLC Lawsuit - AZN - AstraZeneca ( NASDAQ:AZN )

NEW YORK, Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of AstraZeneca PLC AZN. Shareholders who purchased shares of AZN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Source: www.benzinga.com
February 20, 2025 | 18:25:00
Category: News

© Natavest 2025 - 2026